COMP <GO>
NVST vs UNH // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
Envista Holdings Corporation (NYSE) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: NVST 5
— UNH 10
▲ OPTIONS IMPLIED MOVE & PUT/CALL SKEW LEADER: NVST
LAST: $23.51 (-4.47%) • MKT CAP: $3.95B
options-implied-move
6.70%
LAST: $406.97 (-0.96%) • MKT CAP: $364.66B
options-implied-move
6.74%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NVST VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NVST | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 54.70% | 88.57% | -33.87 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 5.10% | 11.47% | -6.37 | UNH | /roic <GO> |
| EV/EBITDA & P/E Valuation | 16.5x | 16.4x | +0.05 | UNH | /valuation <GO> |
| Free Cash Flow Yield | 5.83% | 6.48% | -0.65 | UNH | /fcf-yield <GO> |
| Operating Margin | 7.90% | 4.82% | +3.08 | NVST | /operating-margins <GO> |
| Net Profit Margin | 1.70% | 3.14% | -1.44 | UNH | /net-margins <GO> |
| Revenue Growth (YoY) | 8.30% | 6.46% | +1.84 | NVST | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.28% | -2.28 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.61 | 3.12 | -1.51 | UNH | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 7/9 | +2.00 | NVST | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | 6.70% | 6.74% | -0.04 | NVST | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 47.7 | 56.0 | -8.39 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.93 | 0.33 | +0.60 | NVST | /macro-sensitivity <GO> |
| Forward P/E Multiple | 78.2x | 17.1x | +61.11 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.95B | $364.66B | -$360.71B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NVST REV | UNH REV | NVST GROSS % | UNH GROSS % | NVST FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.72B | $447.57B | 54.7% | 88.7% | $230.4M | $16.07B |
| FY 2024 | $2.51B | $400.28B | 54.7% | 88.3% | $302.7M | $20.70B |
| FY 2023 | $2.57B | $371.62B | 44.0% | 89.6% | $160.2M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NVST // BETA 0.93
UNH // BETA 0.33